AAPL (4/29/12, -6.02%)
ALXN (7/24/11, +46.30%)
ULTA (4/8/12, -7.45%)
MNST (10/16/11, +51.65%)
DG (4/8/12, -0.11%)
DLTR (9/4/11, +44.24%)
MA (9/24/11, +25.33%)
TJX (3/25/12, +6.78%)
FFIV (4/29/12, -7.49%)
Additions:
None
Subtractions:
NSR (4/29/12, -6.65%)
Last week, all the major U.S. indexes lost ground again. The Dow gave up 1.7%, the NYSE composite lost 1.5%, the S&P 500 dipped 1.1%, and the Nasdaq faded 0.8%. The IBD outlook remains at “market in correction”. It’s hard to say which way the markets will move this week, but the bias would seem to be to the downside. Besides the Facebook IPO, tentatively scheduled for Friday, there’s not much for the Bulls to get excited about. Continue to watch from the sidelines, keep your powder dry and your watch lists updated until the next confirmed uptrend comes along, as it always does.
With the market in correction, none of the watch list stocks can be considered as buy candidates.
/as usual, your mileage may vary, always do your own homework
Bonus content:
The following stocks currently exhibit potential technical characteristics consistent with historically successful shorting opportunities, emphasis on POTENTIAL:
INCORRECTLY SHORTING STOCKS CAN LEAD TO UNLIMITED LOSSES. Proceed at your own risk.
/How to Make Money Selling Stocks Short by William J. O’Neil
Filed under: Blog Entry Tagged: | IBD, Investing, Investors Business Daily, Stocks, Watch List
